Reuters logo
13 天前
BRIEF-Endo says continues to expect total generics segment to decline in the high single to low double digits pct range in 2017
2017年8月8日 / 下午3点32分 / 13 天前

BRIEF-Endo says continues to expect total generics segment to decline in the high single to low double digits pct range in 2017

Aug 8 (Reuters) - Endo International Plc

* Endo CEO says continues to expect total generics segment to decline in the high single to low double digits percentage range in 2017 - Conf Call

* Endo CEO says now project full year sterile injectables revenues growth in the low to mid-20 percent range - Conf Call

* Endo says expect overall branded revenue to decline in the mid to high teens percent range y-o-y based on continued generic competition and the withdrawal of Opana ER

* Endo says expect 2017 international revenues to decline in the low 20s percentage range - Conf Call Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below